Looking to learn what, if anything, radiology groups, imaging centers and hospitals are advising patients as part of the "informed consent" process about the fact that small amounts of gadolinium can remain in the patient's body after its use for:
1) intravenous injection of gadolinium contrast medium for MRI/MRA studies. Do you have patients read and sign an acknowledgement that they have received the FDA's medication guide for the gadolinium contrast agent?
2) as an alternative agent to iodine contrast for certain off label uses like joint injections for pain treatment.
Thanks.
------------------------------
Thomas Greeson JD, FRBMA
Partner
Reed Smith LLP
Mc Lean VA
(703) 641-4242
------------------------------